Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2677 |
|
| Actual shortage: | 255 (10%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2413 (90%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
24 (9%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-TOPISONE | 0.05% | LOTION | Actual shortage | 2024-05-09 | 2024-05-09 | 227462 |
| TEVA-SERTRALINE | 50MG | CAPSULE | Actual shortage | 2024-05-09 | 2024-05-09 | 227465 |
| TEVA-PRAVASTATIN | 10MG | TABLET | Actual shortage | 2024-05-09 | 2024-05-09 | 227468 |
| TEVA-CARVEDILOL | 3.125MG | TABLET | Actual shortage | 2024-05-09 | 2024-05-09 | 227471 |
| TEVA-CARVEDILOL | 6.25MG | TABLET | Actual shortage | 2024-05-09 | 2024-05-09 | 227474 |
| TEVA-LATANOPROST | 50MCG | SOLUTION | Actual shortage | 2024-05-09 | 2024-05-09 | 227477 |
| TEVA-MIRTAZAPINE | 30MG | TABLET | Actual shortage | 2024-05-09 | 2024-05-09 | 227480 |
| ACT PIOGLITAZONE | 15MG | TABLET | Actual shortage | 2024-05-09 | 2024-05-09 | 227483 |
| ACT PIOGLITAZONE | 30MG | TABLET | Actual shortage | 2024-05-09 | 2024-05-09 | 227486 |
| TEVA-EZETIMIBE | 10MG | TABLET | Actual shortage | 2024-05-09 | 2024-05-09 | 227489 |
| ACT RIZATRIPTAN | 10MG | TABLET | Actual shortage | 2024-05-09 | 2024-05-09 | 227492 |
| TEVA-TOBRAMYCIN | 60MG | SOLUTION | Actual shortage | 2024-05-09 | 2024-05-09 | 227495 |
| TEVA-VORICONAZOLE | 50MG | TABLET | Actual shortage | 2024-05-09 | 2024-05-09 | 227500 |
| TEVA-VORICONAZOLE | 200MG | TABLET | Actual shortage | 2024-05-09 | 2024-05-09 | 227503 |
| FENTORA | 800MCG | TABLET (EFFERVESCENT) | Actual shortage | 2024-05-09 | 2024-05-09 | 227506 |
| TEVA-EVEROLIMUS | 5MG | TABLET | Actual shortage | 2024-05-09 | 2024-05-09 | 227509 |
| TEVA-DILTIAZEM XC | 360MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-03-07 | 2024-05-09 | 221546 |
| TEVA-TELMISARTAN | 80MG | TABLET | Resolved | 2023-10-12 | 2024-05-09 | 206898 |
| TEVA-FENTANYL | 100MCG | PATCH | Resolved | 2024-01-25 | 2024-05-09 | 217223 |
| TEVA-NAPROXEN | 500MG | TABLET | Resolved | 2024-02-01 | 2024-05-09 | 218126 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64544 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64547 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64550 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64553 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64589 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64592 | ||
| RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64595 | ||
| RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64598 | ||
| TEVA-ATORVASTATIN | 10MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64601 |
| TEVA-ATORVASTATIN | 10MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64606 |
| TEVA-ATORVASTATIN | 20MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64609 |
| TEVA-ATORVASTATIN | 20MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64612 |
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64615 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64623 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64626 | ||
| TEVA-QUETIAPINE | 100MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64846 |
| TEVA-QUETIAPINE | 25MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64849 |
| RATIO-ATORVASTATIN | Discontinued | 2018-10-19 | 2018-10-19 | 64852 | ||
| TEVA-ENALAPRIL | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64855 |
| TEVA-ENALAPRIL | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64858 |